Transforming Growth Factor-alpha reduces carcinogen-induced DNA damage in mini-organ cultures from head-and-neck cancer patients

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 677, Issue 1-2, 2009, Pages 42-45

  Baumeister, Philipp ^a   Schwenk Zieger, Sabina ^a   Reiter, Maximilian ^a   Welz, Christian ^a   Harréus, Ulrich ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

BPDE; Comet assay; EGFR; Mucosa tissue cultures; TGF

Indexed keywords

BENZO(A)PYRENE DIOLEPOXIDE; CARCINOGEN; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL VIABILITY; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA FRAGMENTATION; DNA REPAIR; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; DNA DAMAGE; DNA FRAGMENTATION; DNA REPAIR; HEAD AND NECK NEOPLASMS; HUMANS; HYDROGEN PEROXIDE; MOUTH MUCOSA; ORGAN CULTURE TECHNIQUES; RESPIRATORY MUCOSA; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 67650021205     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2009.05.019     Document Type: Article

References (17)

1. Kalyankrishna S., and Grandis J.R. Epidermal growth factor receptor biology in head and neck cancer. Journal of Clinical Oncology 24 (2006) 2666-2672
2. Grandis J.R., Melhem M.F., et al. Quantitative immunohistochemical analysis of TGF-α and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Cancer 78 (1996) 1284-1293
3. Voldborg B.R., Damstrup L., Spang-Thomsen M., and Poulsen H.S. Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials. Annals of Oncology 8 (1997) 1197-1206
4. Wells A. EGF receptor. The International Journal of Biochemistry and Cell Biology 31 (1999) 637-643
5. Kleinsasser N.H., Juchhoff J., Wallner B.C., Bergner A., Harréus U.A., Gamarra F., Bührlen M., Huber R.M., and Rettenmeier A.W. The use of mini-organ cultures of human upper aerodigestive tract epithelia in ecogenotoxicology. Mutation Research 561 (2004) 63-73
6. Hartmann A., Agurell E., Beevers C., Brendler-Schwaab S., Burlinson B., Clay P., Collins A., Smith A., Speit G., Thybaud V., and Tice R.R. Recommendations for conducting the in vivo alkaline Comet assay. Proceedings of the 4th International Comet Assay Workshop. Mutagenesis 18 (2003) 45-51
7. Lo H.W., and Hung M.C. Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival. British Journal of Cancer 94 (2006) 184-188
8. Vermorken J.B., Mesia R., Rivera F., Remenar E., Kawecki A., Rottey S., Erfan J., Zabolotnyy D., Kienzer H.R., Cupissol D., Peyrade F., Benasso M., Vynnychenko I., De Raucourt D., Bokemeyer C., Schueler A., Amellal N., and Hitt R. Platinum-based chemotherapy plus cetuximab in head and neck cancer. New England Journal of Medicine 359 (2008) 1116-1127
9. Shin D.M., Donato N.J., Perez-Soler R., Shin H.J., Wu J.Y., Zhang P., Lawhorn K., Khuri F.R., Glisson B.S., Myers J., Clayman G., Pfister D., Falcey J., Waksal H., Mendelsohn J., and Hong W.K. Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer. Clinical Cancer Research 7 (2001) 1204-1213
10. Watkins D., and Cunningham D. The role of epidermal growth factor receptor-targeted antibody therapy in previously treated colorectal cancer. Clinical Colorectal Cancer 6 Suppl. 2 (2007) 47-52
11. Pinedo H.M., and Giaccone G. P-glycoprotein-a marker of cancer-cell behavior. New England Journal of Medicine 333 (1995) 1417-1419
12. Sarkadi B., Homolya L., et al. Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. Physiological Reviews 86 (2006) 1179-1236
13. Rohlff C., and Glazer RI. Topical review-regulation of multidrug resistance through the cAMP and EGF signalling pathways. Cellular Signalling 7 (1995) 431-443
14. Scotto, and KW. Transcriptional regulation of ABC drug transporters. Oncogene 22 (2003) 7496-7511
15. Meyer zu Schwabedissen H.E., Grube M., Dreisbach A., Jedlitschky G., Meissner K., Linnemann K., Fusch C., Ritter C.A., Völker U., and Kroemer H.K. Epidermal growth factor-mediated activation of the map kinase cascade results in altered expression and function of ABCG2 (BCRP). Drug Metabolism and Disposition 34 (2006) 524-533
16. Ferguson L.R., and De Flora S. Multiple drug resistance, antimutagenesis and anticarcinogenesis. Mutation Research 591 (2005) 24-33
17. Pandur S., Pankiv S., Johannessen M., Moens U., and Huseby N.E. Gamma-glutamyltransferase is upregulated after oxidative stress through the Ras signal transduction pathway in rat colon carcinoma cells. Free Radical Research 41 (2007) 1376-1384